152 results
Page 2 of 8
8-K
EX-99.1
u5wnyg 89z6cxwevnz9
20 Apr 23
Heron Therapeutics Announces Commercial Leadership Changes
9:10am
8-K
EX-99.1
5c1k3ae61
3 Apr 23
Heron Therapeutics Announces New CEO and Board Chairman
9:10am
8-K
EX-99.1
stpzw
29 Dec 22
Other Events
9:10am
8-K
EX-99.1
fjfeun1t
8 Nov 22
Results of Operations and Financial Condition
4:10pm
424B5
y4rm4
20 Oct 22
Prospectus supplement for primary offering
4:06pm
8-K
EX-99.1
5yduwyhsp2a9lss8
19 Sep 22
Other Events
8:00am
8-K
EX-99.1
emy5uv
9 Aug 22
Results of Operations and Financial Condition
8:20am
8-K
EX-99.1
ozn6re
30 Jun 22
Heron Therapeutics Announces Restructuring and Cost Reduction Plan to Address Market Dynamics and Prepare for Long-Term Sustainability
8:40am
8-K
EX-99.1
cbdv skawqp9vohtdo9
14 Jun 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
lmk23grtn1ts qzc8gxk
9 May 22
Results of Operations and Financial Condition
12:00am
8-K
EX-99.1
0726g5g
25 Mar 22
Regulation FD Disclosure
8:40am
8-K
EX-99.1
tmclp
17 Mar 22
Heron Therapeutics Announces Approval of ZYNRELEF® by Health Canada for the Management of Postoperative Pain
8:45am